Clinical Trials Arena on MSN9d
Neuspera neuromodulation device hits “gold standard” in incontinence trial
Neuspera Medical’s percutaneous sacral neuromodulation (pSNM) has hit the “gold standard”, with 84.2% of patients suffering ...